Prime Medicine
PRME----
Prime Medicine (PRME)
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Prime Medicine Analyst Rating
View MoreForecast & Rating
Jul 9, 2026Price forecast
$7.12134.50%
Forecast & RatingBuy
13analysts
- Strong buy69.23%
- Buy7.69%
- Hold23.08%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 11 hours ago
Cathie Wood Bets Big on SpaceX Even as Elon Musk Warns Short Sellers — Ark Keeps Dumping Robinhood Shares
- Market Beat · Jul 13 at 12:00 PM
Prime Medicine (NASDAQ:PRME) Shares Down 6.5% - Should You Sell?
- Tip Ranks · Jul 11 at 09:35 AM
LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)
- Unusual Whales · Jul 8 at 01:27 PM
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle
- PUBT · Jul 8 at 07:22 AM
Prime Medicine posts corporate deck highlighting prime-editing platform, lead programs in Wilson disease and AATD
- PUBT · Jul 8 at 07:04 AM
Prime Medicine wins arbitration with Beam over AATD therapy PM647
